Risk of Long-Term Mortality for Complex Chronic Patients with Intracerebral Hemorrhage: A Population-Based e-Cohort

Maria Antonia González-Henares1,2, Jose Luis Clua-Espuny3,4, Blanca Lorman-Carbo5

  • 1EAP-Alcanar-St Carlos de la Rápita, Catalonian Health Institute, SAP Terres de l'Ebre, Health Department, Generalitat de Catalunya, CAP St Carles de la Rápita, 43540, Sant Carles de la Ràpita, Spain.

Advances in Therapy
|December 28, 2019
PubMed

Insights

A new prognostic tool shows promise for predicting mortality after hemorrhagic stroke in primary care. However, its effectiveness was not confirmed in complex chronic patients.

Area of Science:

  • Gerontology
  • Neurology
  • Public Health

Background:

  • Hemorrhagic stroke (ICH) poses a significant mortality risk, particularly in older adults.
  • Accurate prognostic tools are crucial for managing complex chronic patients post-ICH in primary care settings.

Purpose of the Study:

  • To develop and validate a prognostic life table for complex chronic patients following an intracerebral hemorrhage (ICH) episode.
  • To assess the predictive accuracy of a novel clinical scale (ICH-AP) for mortality in primary care patients post-ICH.

Main Methods:

  • A multicenter, retrospective study identified a cohort of older adults (≥65 years) with ICH.
  • Cox regression, Kaplan-Meier curves, and ROC analysis were used to develop and validate a mortality prediction model.
  • External validation was performed using prospective monitoring of complex chronic patients.

Main Results:

  • The study identified age >80 years and HAS-BLED score as independent predictors of mortality post-ICH.
  • The developed model (ICH-AP) showed optimal internal validation in the general population.
  • External validation of the ICH-AP model in complex chronic patients was not statistically significant (log-rank p=0.104).

Conclusions:

  • The ICH-AP clinical scale may enhance prognostic prediction for general populations post-ICH in primary care.
  • The prognostic tool's effectiveness was not validated in the complex chronic patient population.
  • Further research is needed to refine prognostic models for complex chronic patients post-ICH.
Abstract

Related Concept Videos